Stay informed with the latest updates for the inheritable blood disorders community. Industry First Patient Enrolled in ITI Trial Using Eloctate Nov 21, 2017 Medical FDA Approves Once-Weekly Subcutaneous Therapy for Hemophilia…Nov 16, 2017 Advocacy & Legislative Call to Action on Senate Tax PlanNov 16, 2017 Medical THSNA Summit Coming in March 2018Nov 15, 2017 Medical Psychosocial Needs of Aging Patients with Hemophilia the Focus of…Nov 13, 2017 Industry Alnylam Announces Successful Meeting with FDA on Fitusiran Nov 13, 2017 Medical NHF Awards Three Judith Graham Pool Postdoctoral Research FellowshipsNov 9, 2017 Medical New Educational Webinars for Healthcare Providers Outside HematologyNov 9, 2017 Industry Study Shows Positive Joint Outcomes in…Nov 6, 2017 Industry FDA Accepts Application for Bayer’s Investigational Hemophilia A TherapyNov 6, 2017 Industry FDA Grants Breakthrough Therapy Designation for…Oct 30, 2017 Medical Partners Clinical Management Module Focuses on ITI and InhibitorsOct 27, 2017 Industry Shire’s Hemophilia Gene Therapy Granted Orphan Drug Status by FDAOct 27, 2017 Advocacy & Legislative Joint Endorsement of Alexander-MurrayOct 26, 2017 Industry UniQure’s Investigational Hemophilia B Gene Therapy to Move Forward in…Oct 20, 2017 Pagination First page Previous page … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Next page Last page